Speciality Medi.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
159.95
5.15 (3.33%)
BSENSE

Nov 20

BSE+NSE Vol: 15000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

15.0 k (226.09%) Volume

Shareholding (Sep 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

43.43%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 136 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.12

stock-summary
Return on Equity

16.27%

stock-summary
Price to Book

1.70

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.72%
0%
1.72%
6 Months
-30.89%
0%
-30.89%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Speciality Medi. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Board Meeting Outcome for Outcome Of Board Meeting Held On November 12 2026 - Financial Result For The Half Year Ended On 30/09/2026

12-Nov-2026 | Source : BSE

We hereby inform you that the Board of Directors of the Company in their Board Meeting held on today i.e. on November 12 2026 at the Corporate Office of the Company which was commenced at 03:30 P.M. and concluded at 04:15 P.M. have apart from other businesses considered approved and taken on record the Unaudited Standalone Financial Results of the Company for the half year ended on September 30 2026 along with Limited Review Reports. We attached herewith financial result for the half year ended on September 30 2026

Results-Financial Result For The Half Year Ended On September 30 2026

12-Nov-2026 | Source : BSE

We hereby submit the Standalone Unaudited Financial Result for the half year ended on September 30 2026

Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday November 12 2026.

05-Nov-2026 | Source : BSE

Speciality Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve 1. Unaudited Standalone Financial Results for the half year ended on September 30 2026.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
65.40%
EBIT Growth (5y)
64.05%
EBIT to Interest (avg)
8.05
Debt to EBITDA (avg)
0.42
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
1.17
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
23.33%
ROE (avg)
20.90%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
40
Price to Book Value
1.76
EV to EBIT
9.71
EV to EBITDA
9.59
EV to Capital Employed
1.86
EV to Sales
1.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
19.11%
ROE (Latest)
16.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Sideways
KST
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Parthkumar Babulal Goyani (21.12%)

Highest Public shareholder

Aparna Samir Thakker (7.33%)

Individual Investors Holdings

51.15%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Speciality Medi."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Speciality Medi."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Speciality Medi."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Speciality Medi."
  }
]
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details